Antiepileptic Drugs, Polypharmacy, and Quality of Life in People Living with Epilepsy Managed in General PracticeFunding This work was funded by UCB Pharma.
Objective Recently, instances of general practitioners (GPs) prescribing antiepileptic drugs (AEDs) have increased. We aimed to investigate the use of AEDs in a community sample of people with epilepsy and the effect on quality of life (QoL).
Methods Responses from the Australian Epilepsy Longitudinal Study (AELS), Pharmaceutical Benefit Scheme (PBS), and Medicare Benefit Scheme (MBS) data were used. Linear regression was used to investigate the relationship between the numbers of AEDs and QoL.
Results Fifty people with epilepsy were prescribed an average of two AEDs. The most common were lamotrigine, sodium valproate, and levetiracetam. Eighty-two percent were prescribed medications from two or more categories of medications. A lower QoL at wave 2 of the AELS was significantly associated with a higher number of AEDs.
Conclusion Given the high number of people with epilepsy being cared for in general practice, GPs must understand the risks and benefits of epilepsy monotherapy, polytherapy, and polypharmacy.
04 June 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Brown K. Indicators of the social consequences of epilepsy. In: Pinicinhara J, Walker C, eds. Society Behaviour and Epilepsy. New York: Nova Biomedical 2011: 17-28
- 2 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (04) 475-482
- 3 Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ 2014; 348: g254
- 4 Tan M. Epilepsy in adults. Aust Fam Physician 2014; 43 (03) 100-104
- 5 Hollingworth SA, Eadie MJ. Antiepileptic drugs in Australia: 2002-2007. Pharmacoepidemiol Drug Saf 2010; 19 (01) 82-89
- 6 Leong C, Mamdani MM, Gomes T. et al. Antiepileptic use for epilepsy and non-epilepsy disorders: a population-based study (1998-2013). Neurology 2016; 86: 939-946
- 7 Zaccara G, Schmidt D. Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development. Pharmacol Res 2016; 104: 38-48
- 8 Wilby J, Kainth A, Hawkins N. et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 2005; 9 (15) 1-157, iii–iv
- 9 Talati R, Scholle JM, Phung OJ. et al. Effectiveness and safety of antiepileptic medications in patients with epilepsy. Comparative Effectiveness Review No 40. Agency for Healthcare Quality and Research. Rockville: AHRQ Publications; 2011
- 10 Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med 2011; 365 (10) 919-926
- 11 St Louis EK. Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 2009; 7 (02) 106-114
- 12 Rational AED. Polypharmacy—what are the criteria for providing optimal care?. Neurol Rev 2009; 17: 3-12
- 13 Schmidt D. Drug treatment strategies for epilepsy revisited: starting early or late? One drug or several drugs?. Epileptic Disord 2016; 18 (04) 356-366
- 14 Polypharmacy alone worsens quality of life in epilepsy. Editorial Neurology Advisor Dec 2016 Reporting on Briglia H, Quigg M, Broshek D. Polypharmacy is associated with worse quality of life in epilepsy. Presented at: 2016 American Epilepsy Society Annual Meeting. December 2–6, 2016; Houston, TX. Available at: http://www.neurologyadvisor.com/aes-2016-coverage/polypharmacy-alone-worsens-quality-of-life-in-epilepsy/article/576857. Accessed March 3, 2017
- 15 Alexander HB, Broshek DK, Quigg M. Quality of life in adults with epilepsy is associated with anticonvulsant polypharmacy independent of seizure status. Epilepsy Behav 2018; 78: 96-99
- 16 George J, Kulkarni C, Sarma GRK. Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study. Value Health Reg Issues 2015; 6: 1-6
- 17 Pirio Richardson S, Farias ST, Lima III AR, Alsaadi TM. Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy. Epilepsy Behav 2004; 5 (03) 343-347
- 18 Suurmeijer TPBM, Reuvekamp MF, Aldenkamp BP. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia 2001; 42 (09) 1160-1168
- 19 Uijl SG, Uiterwaal CS, Aldenkamp AP. et al. Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trial. Eur J Neurol 2009; 16 (11) 1173-1177
- 20 Vickery BG, Perrine KR, Hays RO. et al. Quality of life in epilepsy QOLIE-31(Version 1.0) Scoring Manual, US: Rand. 1993
- 21 IBM Corp. IBM SPSS Statistics for Windows, Version 24.0. 2016; Armonk, NY: IBM Corp
- 22 World Health Organization (WHO). Anatomical Therapeutical Chemical Classification. Uppsala, Sweden: Nordic Council on Medicines 1997